David Johnson
Direktor/Vorstandsmitglied bei CARIBOU BIOSCIENCES, INC.
Vermögen: - $ am 31.05.2024
Aktive Positionen von David Johnson
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CARIBOU BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | 11.05.2022 | - |
Independent Dir/Board Member | 11.05.2022 | - |
Karriereverlauf von David Johnson
Ehemalige bekannte Positionen von David Johnson
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
GLOBAL BLOOD THERAPEUTICS, INC. | Corporate Officer/Principal | 12.03.2018 | 01.12.2022 |
GILEAD SCIENCES, INC. | Vertrieb & Marketing | 01.01.2003 | 01.01.2018 |
Ausbildung von David Johnson
University of Puget Sound | Undergraduate Degree |
Kenan-Flagler Business School | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 6 |
Operativ
Corporate Officer/Principal | 1 |
Undergraduate Degree | 1 |
Masters Business Admin | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
GILEAD SCIENCES, INC. | Health Technology |
CARIBOU BIOSCIENCES, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Global Blood Therapeutics, Inc.
Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir, and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA. | Health Technology |
- Börse
- Insiders
- David Johnson
- Erfahrung